Paralysis only slightly reduces the febrile response to interleukin-2 during isoflurane anesthesia

R Lenhardt1, C Negishi, D I Sessler

  • 1Department of Anesthesia and Perioperative Care, University of California, San Francisco 94143, USA.

Anesthesiology
|September 22, 1998
PubMed
Abstract

Insights

Paralysis during anesthesia did not significantly alter core body temperature despite reducing heat production. Muscle relaxants do not explain the rarity of intraoperative fever.

Area of Science:

  • Anesthesiology
  • Physiology
  • Thermoregulation

Background:

  • Intraoperative fever is rare despite common pyrogenic causes.
  • Volatile anesthetics inhibit fever dose-dependently.
  • Muscle paralysis may reduce fever by preventing shivering-induced heat production.

Purpose of the Study:

  • To test if paralysis during anesthesia decreases the febrile response to pyrogen administration.

Main Methods:

  • Seven volunteers received interleukin-2, followed by isoflurane anesthesia.
  • Volunteers were assigned to either paralysis with vecuronium or no muscle relaxants.
  • Body heat content and distribution were measured using tissue and skin temperatures.

Main Results:

  • Peak core temperatures were similar between paralyzed (37.2°C) and unparalyzed (37.6°C) days.
  • Body heat content increased in unparalyzed volunteers but decreased significantly when paralyzed.
  • Peripheral tissue heat content decreased during paralysis.

Conclusions:

  • Paralysis prevented shivering, leading to decreased body heat content.
  • Thermoregulatory vasoconstriction maintained similar core temperatures despite paralysis.
  • Muscle relaxants are not the primary reason for low intraoperative fever.

Related Concept Videos

Classification of Skeletal Muscle Relaxants01:28

Classification of Skeletal Muscle Relaxants

Skeletal muscle relaxants are a group of drugs that can reduce muscle stiffness and induce temporary paralysis to relieve pain. These agents can act centrally to reduce muscle tone or spasms in painful conditions such as multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), or spinal injuries; they are called antispasmodics or spasmolytics.
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
Skeletal Muscle Relaxants: Adverse Effects01:21

Skeletal Muscle Relaxants: Adverse Effects

Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Skeletal Muscle Relaxants: Therapeutic Uses01:31

Skeletal Muscle Relaxants: Therapeutic Uses

Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx as...
Local Anesthetics: Clinical Application as Spinal Anesthesia01:11

Local Anesthetics: Clinical Application as Spinal Anesthesia

Spinal anesthetics are given during lower abdomen and limb surgeries to block sensory and motor neurons. They are administered in the mid to low lumbar regions, primarily acting on the cauda equina's nerve roots. The blockade level depends on the local anesthetic (LA) concentration. Usually, low LA concentrations are sufficient to block sensory fibers, while only high LA concentrations block motor fibers. Other factors like injection volume and speed, the patient's posture, and the drug...
Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
Inhalational Anesthetics: Overview01:20

Inhalational Anesthetics: Overview

Inhalation anesthetics are drugs that induce general anesthesia upon inhalation. They work by increasing the sensitivity of GABAA receptors or inhibiting NMDA receptors, leading to a decrease in central nervous system activity. The depth of anesthesia can be rapidly adjusted by changing the concentration of the inhaled gas. Some common examples of inhalational anesthetics include volatile liquids like isoflurane, desflurane, sevoflurane and gases like xenon and nitrous oxide. Isoflurane, a...